Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: John Burn, Andrzej Jakubowiak, Shaji Kumar, Sagnar Lonial, Gareth Morgan, Antonio Palumbo, and Others

Premium

John Burn has been appointed as a non-executive director of NHS England, QuantuMDx said this week.

Burn serves as chief medical officer for the Newcastle, UK-based company, which is developing a series of chip-based tests. He also holds the NHS endowed chair in clinical genetics at Newcastle University.

Burn's position as non-executive director of NHS England will take effect from July 1 for a period of four years.


Dutch molecular diagnostics company SkylineDx named its scientific advisory board this week.

Members of SkylineDx's newly formed SAB include Andrzej Jakubowiak, a professor of medicine and director of the Myeloma Program at the University of Chicago; Shaji Kumar, a professor of medicine at the Mayo Clinic College of Medicine; Sagar Lonial, a trained bone marrow transplant physician with an interest in molecular therapy for lymphoma and myeloma; Gareth Morgan, director of the Myeloma Institute at the University of Arkansas for Medical Sciences; Antonio Palumbo, chief of the myeloma unit of the department of oncology at the University of Torino in Italy; David Siegel, chief of the division of multiple myeloma at Hackensack University Medical Center; Pieter Sonneveld, head of the department of hematology at Erasmus MC; and Keith Stewart, dean for research at the Mayo Clinic in Arizona.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more